drugset / Trial / NCT01509131

Evaluation of a Mixed Bowel Prep (2L PEG + Bisacodyl) Versus PEG With Ascorbate

NCT01509131

Phase 4 Completed 408 enrolled Promefarm S.r.l.
RandomizedParallel-groupSingle-blindTreatment

Summary

It is hypothesized that PEG 2L with citrate and simeticone plus bisacodyl will have similar bowel cleansing efficacy versus PEG 2L with ascorbate. Safety, tolerability, acceptance and compliance of the two reduced volume PEG-based bowel preparation will be also compared.

Timeline

Start
2010-03
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bisacodyl Small molecule 10 mg
Subject Bisacodyl Small molecule 20 mg
Subject Lovolesse Unknown 2000 ml
Comparator PEG-Asc Unknown 2000 ml

Indications

No indication recorded.